Ads
related to: indications for lower dose apixaban- Full Prescribing Info
View Prescribing Information For
XARELTO® Tablets
- XARELTO® Cost Info
How Much Will I Need to Pay?
View XARELTO® Savings Information
- XARELTO® FAQs
Find Answers To Frequently Asked
Questions About XARELTO®
- XARELTO® Dosing
View Dosing Guide & Prescribing
Info Across 11 Indications
- Save on XARELTO®
Janssen CarePath Savings Program
2024 Program Requirements Apply
- Visit The Patient Site
Patients - Visit The Official Site
To Learn More About XARELTO®
- Full Prescribing Info
Search results
Results From The WOW.Com Content Network
Apixaban is indicated for the following: [6] To lower the risk of stroke and embolism in people with nonvalvular atrial fibrillation. Deep vein thrombosis (DVT) prevention. DVTs may lead to pulmonary embolism (PE) in knee or hip replacement surgery patients. Treatment of both DVT and PE. To reduce the risk of recurring DVT and PE after initial ...
Compared to the risk of bleeding with warfarin use, direct factor Xa inhibitors have a higher risk of GI bleeding, but lower risk of bleeding in the brain. [2] Other side effects may include stomach upset, dizziness, anemia or increased blood levels of liver enzymes. [2]
It is also used to treat atrial fibrillation to lower the risk of stroke caused by a blood clot. Another indication is a prophylactic treatment for blood clotting due to atherosclerosis. Rivaroxaban was the first FXa inhibitor on the market and then followed by apixaban, edoxaban and betrixaban.
Thrombin demonstrates a high level of allosteric regulation. [2] Allosterism in thrombin is regulated by the exosites 1 and 2 and the sodium binding site. A recent patent review has shown that the general consensus among researchers is that allosteric inhibitors may provide a more regulatable anticoagulant. [3]
Aspirin (low dose) Block cyclooxygenase-1→ reduce thromboxane A2 production → reduce platelet activation and aggregation → reduce plaque formation and risk of adverse cardiovascular events [22] Side effects [23] Increased bleeding risk, especially in the stomach; Gastrointestinal irritation; Used in risk factor control and acute coronary ...
An antiplatelet drug (antiaggregant), also known as a platelet agglutination inhibitor or platelet aggregation inhibitor, is a member of a class of pharmaceuticals that decrease platelet aggregation [1] and inhibit thrombus formation.
An anticoagulant, commonly known as a blood thinner, is a chemical substance that prevents or reduces the coagulation of blood, prolonging the clotting time. [1] Some occur naturally in blood-eating animals, such as leeches and mosquitoes, which help keep the bite area unclotted long enough for the animal to obtain blood.
The opposite of an indication is a contraindication, [4] a reason to withhold a certain medical treatment because the risks of treatment clearly outweigh the benefits. In the United States, indications for prescription drugs are approved by the FDA. Indications are included in the Indications and Usage section of the Prescribing Information.
Ad
related to: indications for lower dose apixaban